A. Antsaklis

Molecular and Proteomic Characterization of Human Mesenchymal Stem Cells Derived from Amniotic Fluid: Comparison to Bone Marrow Mesenchymal Stem Cells

Maria G. Roubelakis, Kalliopi I. Pappa, Vasiliki Bitsika et al. · Stem Cells and Development · 2007 · 284 citations

Life Sciences, Cell Biology, Developmental Biology +13

Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure

Dimitra Zagoura, Maria G. Roubelakis, Vasiliki Bitsika et al. · Gut · 2011 · 182 citations

Life Sciences, Biotechnology, Cell Biology +15

Effects of Donor Age, Gender, and In Vitro Cellular Aging on the Phenotypic, Functional, and Molecular Characteristics of Mouse Bone Marrow-Derived Mesenchymal Stem Cells

Olga Katsara, Louisa G. Mahaira, Eleni G. Iliopoulou et al. · Stem Cells and Development · 2011 · 176 citations

Life Sciences, Cell Biology, Developmental Biology +17

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

N. Gavalas, Marinos Tsiatas, Ourania Tsitsilonis et al. · British Journal of Cancer · 2012 · 168 citations · Full text

Medicine, Immunology, Oncology +17

VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals <i>via</i> VEGF receptor Type 2

Apostolos C Ziogas, Nikos G. Gavalas, Marinos Tsiatas et al. · International Journal of Cancer · 2011 · 168 citations

Medicine, Immunology, Oncology +17